This is a Validated Antibody Database (VAD) review about mouse Plk1, based on 97 published articles (read how Labome selects the articles), using Plk1 antibody in all methods. It is aimed to help Labome visitors find the most suited Plk1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Plk1 synonym: Plk; STPK13

Santa Cruz Biotechnology
mouse monoclonal (3F8)
  • western blot; human; 1:500; loading ...; fig 5g
Santa Cruz Biotechnology Plk1 antibody (Santa Cruz Biotechnology, sc-53751) was used in western blot on human samples at 1:500 (fig 5g). Cell Death Discov (2021) ncbi
mouse monoclonal (F-8)
  • western blot; human; 1:500; loading ...; fig 6c
Santa Cruz Biotechnology Plk1 antibody (Santa, sc-17783) was used in western blot on human samples at 1:500 (fig 6c). J Cell Biol (2020) ncbi
mouse monoclonal (F-8)
  • western blot; human; loading ...; fig 7d
Santa Cruz Biotechnology Plk1 antibody (Santa Cruz, sc-17783) was used in western blot on human samples (fig 7d). Mol Ther Nucleic Acids (2019) ncbi
mouse monoclonal (F-8)
  • western blot; human; 1:100; loading ...; fig 7e
Santa Cruz Biotechnology Plk1 antibody (Santa, sc-17783) was used in western blot on human samples at 1:100 (fig 7e). elife (2019) ncbi
mouse monoclonal (F-8)
  • western blot; mouse; loading ...; fig 1a
Santa Cruz Biotechnology Plk1 antibody (Santa Cruz Biotechnology, sc-17783) was used in western blot on mouse samples (fig 1a). Sci Adv (2019) ncbi
mouse monoclonal (F-8)
  • western blot; human; loading ...; fig 1a
Santa Cruz Biotechnology Plk1 antibody (SantaCruz, sc-17783) was used in western blot on human samples (fig 1a). Nature (2018) ncbi
mouse monoclonal (F-8)
  • western blot; human; 1:2000; loading ...; fig s6d
In order to investigate the effect of actomyosin on cell nuclear morphology and genome stability, Santa Cruz Biotechnology Plk1 antibody (Santa Cruz Biotechnology, sc-17783) was used in western blot on human samples at 1:2000 (fig s6d). Nat Commun (2017) ncbi
mouse monoclonal (E-2)
  • western blot; human; 1:1000; loading ...; fig 6b
Santa Cruz Biotechnology Plk1 antibody (Santa Cruz Biotechnology, sc-55504) was used in western blot on human samples at 1:1000 (fig 6b). Exp Ther Med (2017) ncbi
mouse monoclonal (F-8)
  • western blot; human; 1:500; loading ...; fig 6e; S6i
In order to report FOSL1 as a common transcriptional signature across mutant KRAS cancers of distinct tissue origin, Santa Cruz Biotechnology Plk1 antibody (Santa Cruz, sc-17783) was used in western blot on human samples at 1:500 (fig 6e; S6i). Nat Commun (2017) ncbi
mouse monoclonal (F-8)
  • immunocytochemistry; human; 1:200; loading ...; fig s7r
In order to demonstrate that Epstein-Barr virus infection of B-lymphocytes leads to an increased rate of centrosome amplification, Santa Cruz Biotechnology Plk1 antibody (Santa Cruz, sc-17783) was used in immunocytochemistry on human samples at 1:200 (fig s7r). Nat Commun (2017) ncbi
mouse monoclonal (F-8)
  • immunocytochemistry; human; loading ...; fig 2b
In order to research the role of polo like kinase 1 in MTOR complex 1 and autophagy, Santa Cruz Biotechnology Plk1 antibody (Santa Cruz, sc-17783) was used in immunocytochemistry on human samples (fig 2b). Autophagy (2017) ncbi
mouse monoclonal (E-2)
  • immunoprecipitation; human; loading ...; fig 1a
  • western blot; human; loading ...; fig 1d
In order to research the role of polo like kinase 1 in MTOR complex 1 and autophagy, Santa Cruz Biotechnology Plk1 antibody (Santa Cruz, sc-55504) was used in immunoprecipitation on human samples (fig 1a) and in western blot on human samples (fig 1d). Autophagy (2017) ncbi
mouse monoclonal (F-8)
  • immunohistochemistry; human; 1:25; fig 1
In order to evaluate the therapeutic use of polo-like kinase 1 inhibition to treat melanoma, Santa Cruz Biotechnology Plk1 antibody (Santa Cruz, sc-17783) was used in immunohistochemistry on human samples at 1:25 (fig 1). Cancer Lett (2017) ncbi
mouse monoclonal (F-8)
  • western blot; human; loading ...; fig 1c
In order to elucidate how Cdh1 regulates NEDD4 family E3 ligases such as WWP2, Santa Cruz Biotechnology Plk1 antibody (Santa Cruz, F-8) was used in western blot on human samples (fig 1c). Cell Discov (2016) ncbi
mouse monoclonal
  • western blot; human; loading ...; fig 1c
In order to elucidate how Cdh1 regulates NEDD4 family E3 ligases such as WWP2, Santa Cruz Biotechnology Plk1 antibody (Santa Cruz, F-8) was used in western blot on human samples (fig 1c). Cell Discov (2016) ncbi
mouse monoclonal (F-8)
  • western blot; human; loading ...; fig 4h
Santa Cruz Biotechnology Plk1 antibody (Santa Cruz Biotechnology, sc-17783) was used in western blot on human samples (fig 4h). J Biol Chem (2016) ncbi
mouse monoclonal (F-8)
  • western blot; human; fig 5
Santa Cruz Biotechnology Plk1 antibody (Santa Cruz, sc-17783) was used in western blot on human samples (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (F-8)
  • immunocytochemistry; human; fig 3
Santa Cruz Biotechnology Plk1 antibody (Santa Cruz, sc-17783) was used in immunocytochemistry on human samples (fig 3). J Cell Biol (2016) ncbi
mouse monoclonal (F-8)
  • western blot; human; 1:50; fig 3
In order to study APC/C(Cdh1) function, Santa Cruz Biotechnology Plk1 antibody (Santa Cruz, sc-17783) was used in western blot on human samples at 1:50 (fig 3). Nucleic Acids Res (2016) ncbi
mouse monoclonal (F-8)
  • immunocytochemistry; human; fig 4
  • western blot; human; fig 1
Santa Cruz Biotechnology Plk1 antibody (Santa Cruz Biotechnology, sc-17783) was used in immunocytochemistry on human samples (fig 4) and in western blot on human samples (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (F-8)
  • western blot; human; fig 2
Santa Cruz Biotechnology Plk1 antibody (Santa Cruz, sc-17783) was used in western blot on human samples (fig 2). Sci Rep (2016) ncbi
mouse monoclonal (3F8)
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, Santa Cruz Biotechnology Plk1 antibody (SCBT, 3F8) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (F-8)
  • western blot; mouse; loading ...; fig 9c
In order to present the role of nuclear pore protein nup88 on anaphase-promoting complex, Santa Cruz Biotechnology Plk1 antibody (Santa Cruz, sc-17783) was used in western blot on mouse samples (fig 9c). J Clin Invest (2016) ncbi
mouse monoclonal (36-298)
  • western blot; human; 1:500; fig 4b
Santa Cruz Biotechnology Plk1 antibody (santa cruz, sc-56948) was used in western blot on human samples at 1:500 (fig 4b). Biol Open (2015) ncbi
mouse monoclonal (F-8)
  • immunocytochemistry; mouse; 1:300; fig 4
Santa Cruz Biotechnology Plk1 antibody (Santa Cruz, sc-17783) was used in immunocytochemistry on mouse samples at 1:300 (fig 4). Nat Commun (2015) ncbi
mouse monoclonal (F-8)
  • western blot; human; fig 4a
Santa Cruz Biotechnology Plk1 antibody (Santa Cruz, sc-17783) was used in western blot on human samples (fig 4a). Oncogenesis (2015) ncbi
mouse monoclonal (F-8)
  • western blot; human; 1:500; fig s13
Santa Cruz Biotechnology Plk1 antibody (Santa Cruz, sc-17783) was used in western blot on human samples at 1:500 (fig s13). Nat Commun (2015) ncbi
mouse monoclonal (F-8)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 1
Santa Cruz Biotechnology Plk1 antibody (Santa Cruz, sc17783) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (F-8)
  • western blot; human; fig 1
Santa Cruz Biotechnology Plk1 antibody (Santa Cruz, sc-17783) was used in western blot on human samples (fig 1). Cell Cycle (2015) ncbi
mouse monoclonal (F-8)
  • western blot; human; fig 1
In order to explore how Tpr regulated chromosomal segregation, Santa Cruz Biotechnology Plk1 antibody (Santa Cruz Biotechnology, sc-17783) was used in western blot on human samples (fig 1). Cell Cycle (2015) ncbi
mouse monoclonal (F-8)
  • western blot; human
In order to study the effect of MASTL on cyclin B1 degradation and its mechanism, Santa Cruz Biotechnology Plk1 antibody (Santa Cruz, sc-17783) was used in western blot on human samples . Biol Open (2015) ncbi
mouse monoclonal (F-8)
  • western blot; human; fig 5
Santa Cruz Biotechnology Plk1 antibody (Santa Cruz Biotechnology, F-8) was used in western blot on human samples (fig 5). Biol Open (2015) ncbi
mouse monoclonal (F-8)
  • western blot; human; fig 5
Santa Cruz Biotechnology Plk1 antibody (Santa Cruz, sc-17783) was used in western blot on human samples (fig 5). Cell Cycle (2014) ncbi
mouse monoclonal (E-2)
  • immunocytochemistry; human
In order to elucidate the mechanism by which BI2536 induces defects in cell proliferation of non-small cell lung cancer, Santa Cruz Biotechnology Plk1 antibody (Santa Cruz, sc55504) was used in immunocytochemistry on human samples . Cancer Lett (2015) ncbi
mouse monoclonal (F-8)
  • western blot; human
Santa Cruz Biotechnology Plk1 antibody (Santa Cruz Biotechnology, SC-17783) was used in western blot on human samples . J Cell Biol (2014) ncbi
mouse monoclonal (F-8)
  • western blot; human
Santa Cruz Biotechnology Plk1 antibody (Santa Cruz Biotechnology, sc-17783) was used in western blot on human samples . J Biol Chem (2015) ncbi
mouse monoclonal (F-8)
  • western blot; human
In order to investigate the role of Rap1GAP in the cell cycle regulation, Santa Cruz Biotechnology Plk1 antibody (Santa Cruz Biotechnology, sc-17783) was used in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (F-8)
  • western blot; human; 1:2000; fig 2
Santa Cruz Biotechnology Plk1 antibody (Santa Cruz, sc-17783) was used in western blot on human samples at 1:2000 (fig 2). Nat Commun (2014) ncbi
mouse monoclonal (F-8)
  • immunoprecipitation; human
  • immunocytochemistry; human
  • western blot; human
Santa Cruz Biotechnology Plk1 antibody (Santa Cruz, sc-17783) was used in immunoprecipitation on human samples , in immunocytochemistry on human samples and in western blot on human samples . Clin Cancer Res (2014) ncbi
mouse monoclonal (F-8)
  • immunoprecipitation; human
  • immunocytochemistry; human
  • western blot; human
Santa Cruz Biotechnology Plk1 antibody (Santa Cruz, sc-17783) was used in immunoprecipitation on human samples , in immunocytochemistry on human samples and in western blot on human samples . Mol Oncol (2014) ncbi
mouse monoclonal (3F8)
  • western blot; human; 1:1000
In order to show that during cytokinesis aurora B coordinates with Plk1 to regulate MyoGEF activation and localization, Santa Cruz Biotechnology Plk1 antibody (Santa, sc-53751) was used in western blot on human samples at 1:1000. J Biol Chem (2014) ncbi
mouse monoclonal (F-8)
  • western blot; human; fig 2
Santa Cruz Biotechnology Plk1 antibody (Santa Cruz, sc17783) was used in western blot on human samples (fig 2). Cell (2014) ncbi
mouse monoclonal (F-8)
  • immunocytochemistry; human; 1:500
Santa Cruz Biotechnology Plk1 antibody (Santa Cruz, sc-17783) was used in immunocytochemistry on human samples at 1:500. PLoS ONE (2012) ncbi
Invitrogen
mouse monoclonal (PL6/PL2)
  • western blot; human; 1:1000; loading ...; fig 4d
In order to study the effect of environmental and endogenous Toxins on BRCA2 haploinsufficiency and genome instability, Invitrogen Plk1 antibody (ThermoFisher, 33-1700) was used in western blot on human samples at 1:1000 (fig 4d). Cell (2017) ncbi
mouse monoclonal (35-206)
  • western blot; mouse; 1:2000; loading ...; fig 1a
In order to assess structural and biochemical phenotypes of neuronal transcriptional repression-induced atypical cell death in patient brains with Huntington's disease, Invitrogen Plk1 antibody (Invitrogen, 37-7000) was used in western blot on mouse samples at 1:2000 (fig 1a). Acta Neuropathol Commun (2017) ncbi
mouse monoclonal (PL6/PL2)
  • western blot; human; 1:500; fig s1
In order to investigate stabilization of XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma via USP9X, Invitrogen Plk1 antibody (Invitrogen, 33-1700) was used in western blot on human samples at 1:500 (fig s1). EMBO Mol Med (2016) ncbi
mouse monoclonal (35-206)
  • western blot; human; fig 1
In order to utilize DESI MS for PLK1 knockdown in cancer cells to monitor changes in lipid profiles, Invitrogen Plk1 antibody (Invitrogen, 37-7000) was used in western blot on human samples (fig 1). Anal Bioanal Chem (2016) ncbi
mouse monoclonal (35-206)
  • western blot; rat; 1:500; fig 4
In order to study regulation of necrotic cell death induced by transcriptional repression through impaired RNA splicing by the hnRNP-Htt axis, Invitrogen Plk1 antibody (Invitrogen, 37-7000) was used in western blot on rat samples at 1:500 (fig 4). Cell Death Dis (2016) ncbi
mouse monoclonal (36-298)
  • western blot; human; 1:1000; fig 1
In order to research induction of epithelial-to-mesenchymal transition by Polo-like kinase 1 and promotion of epithelial cell motility by activating CRAF/ERK signaling, Invitrogen Plk1 antibody (ThermoFisher Scientific, 36-298) was used in western blot on human samples at 1:1000 (fig 1). elife (2016) ncbi
mouse monoclonal (PL6/PL2)
  • immunoprecipitation; human; fig 4
  • western blot; human; fig 4
In order to investigate the role of topoisomerase IIbeta-binding protein 1 in DNA repair and its contribution to cancer, Invitrogen Plk1 antibody (Zymed, 331700) was used in immunoprecipitation on human samples (fig 4) and in western blot on human samples (fig 4). J Cell Biol (2016) ncbi
mouse monoclonal (PL6/PL2)
In order to analyze G2 checkpoint regulators for hypoxia-induced alterations, Invitrogen Plk1 antibody (Zymed, Zy-1700) was used . Mol Oncol (2016) ncbi
mouse monoclonal (35-206)
  • flow cytometry; human; fig 2
In order to analyze G2 checkpoint regulators for hypoxia-induced alterations, Invitrogen Plk1 antibody (Invitrogen, 37-7000) was used in flow cytometry on human samples (fig 2). Mol Oncol (2016) ncbi
mouse monoclonal (PL6/PL2)
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, Invitrogen Plk1 antibody (INVITROGEN, PL6 and PL2) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (PL6/PL2)
  • western blot; human; 1:500; fig 2
In order to assess the regulation of PLK1 and PCNT cleavage and mitotic exit via centriole separation, Invitrogen Plk1 antibody (Zymed, 33-1700) was used in western blot on human samples at 1:500 (fig 2). Nat Commun (2015) ncbi
mouse monoclonal (36-298)
  • immunohistochemistry; human
In order to study co-expression of of FOXM1 and polo-like kinase 1 in gastric adenocarcinoma patients, Invitrogen Plk1 antibody (Zymed, 37-7100) was used in immunohistochemistry on human samples . BMC Res Notes (2015) ncbi
mouse monoclonal (35-206)
  • western blot; human; fig 5
In order to compare the chemosensitizing effect of nucleoside analogues in cells derived from pancreatic cancer and in osteosarcoma-derived cells, Invitrogen Plk1 antibody (Life Technologies, 37-7000) was used in western blot on human samples (fig 5). Oncotarget (2015) ncbi
mouse monoclonal (35-206)
  • western blot; human; 1:100; fig 7
In order to compare gene expression profiles of oocytes and zygotes and focus on cytokinesis-related genes, Invitrogen Plk1 antibody (Invitrogen, 37-7000) was used in western blot on human samples at 1:100 (fig 7). Sci Rep (2015) ncbi
mouse monoclonal (PL6/PL2)
  • western blot; mouse; fig 1
In order to elucidate how PLK1 regulates cell survival during mTORC1 hyperactivation, Invitrogen Plk1 antibody (Invitrogen, 33-1700) was used in western blot on mouse samples (fig 1). Cell Cycle (2015) ncbi
mouse monoclonal (PL6/PL2)
  • western blot; human
In order to demonstrate that SNW1 and PRPF8 are essential for sister chromatid cohesion in human cells, Invitrogen Plk1 antibody (Zymed, 33-1700) was used in western blot on human samples . EMBO J (2014) ncbi
mouse monoclonal (35-206)
  • western blot; mouse
  • western blot; human
Invitrogen Plk1 antibody (Invitrogen, 35-206) was used in western blot on mouse samples and in western blot on human samples . Oncogene (2015) ncbi
mouse monoclonal (35-206)
  • western blot; human; 1:2500
Invitrogen Plk1 antibody (Epitomics, 37-7000) was used in western blot on human samples at 1:2500. Anticancer Agents Med Chem (2014) ncbi
mouse monoclonal (PL6/PL2)
  • immunoprecipitation; human; fig 2
  • western blot; human; fig 2
In order to report how NFBD1 and PLK1 regulate the G2/M transition, Invitrogen Plk1 antibody (Zymed, PL2) was used in immunoprecipitation on human samples (fig 2) and in western blot on human samples (fig 2). PLoS ONE (2013) ncbi
mouse monoclonal (PL6/PL2)
  • western blot; human; 1:500; fig 5
In order to study the effect of human papillomavirus type 16 E7 oncoprotein on the anaphase promoting complex/cyclosome and its mechanism, Invitrogen Plk1 antibody (Invitrogen, 33-1700) was used in western blot on human samples at 1:500 (fig 5). Virology (2013) ncbi
mouse monoclonal (35-206)
  • western blot; human; fig s2
In order to study the regulation of polo-like kinase 4 activity and centrosome numeral integrity by SAPK pathways and p53, Invitrogen Plk1 antibody (Zymed, 35-206) was used in western blot on human samples (fig s2). Nat Commun (2013) ncbi
mouse monoclonal (PL6/PL2)
  • western blot; human; fig 7
In order to study the mechanism by which human Cdc14A regulates the stability of Wee1, Invitrogen Plk1 antibody (Zymed, 33-1700) was used in western blot on human samples (fig 7). Mol Biol Cell (2012) ncbi
mouse monoclonal (PL6/PL2)
  • western blot; human; 1:300
In order to show that mitosis is a critical step in the cellular response to genotoxic agents in human cells, Invitrogen Plk1 antibody (Zymed Laboratories, 33-1700) was used in western blot on human samples at 1:300. Biochem J (2012) ncbi
mouse monoclonal (PL6/PL2)
  • immunocytochemistry; human; fig 1
  • western blot; human; fig 2
In order to study phosphorylation of RanBP1 by Plk1 during mitosis, Invitrogen Plk1 antibody (Zymed Laboratories, 33-1700) was used in immunocytochemistry on human samples (fig 1) and in western blot on human samples (fig 2). J Biol Chem (2011) ncbi
mouse monoclonal (35-206)
  • western blot; human; 1:200; fig 5
In order to identify and characterize radiation-induced G2-arrest in human B-lymphocyte cancer cell lines, Invitrogen Plk1 antibody (Zymed, 35-206) was used in western blot on human samples at 1:200 (fig 5). Cell Cycle (2011) ncbi
mouse monoclonal (36-298)
  • western blot; human; 1:200; fig 4
In order to determine the function and regulation of polo-like kinase 1 in esophageal cancer, Invitrogen Plk1 antibody (Invitrogen, 36-298) was used in western blot on human samples at 1:200 (fig 4). Int J Cancer (2011) ncbi
mouse monoclonal (PL6/PL2)
  • western blot; human; fig 1
In order to investigate anaphase promoting complex during normal and abnormal mitotic processes, Invitrogen Plk1 antibody (Zymed, 33-1700) was used in western blot on human samples (fig 1). Cell Cycle (2010) ncbi
mouse monoclonal (PL6/PL2)
  • western blot; human; fig 1
In order to assess the role of p21(WAF1) in G2-M phase checkpoint control and in prevention of polyploidy after DNA damage, Invitrogen Plk1 antibody (Zymed, 33-1700) was used in western blot on human samples (fig 1). Mol Biol Cell (2009) ncbi
mouse monoclonal (PL6/PL2)
  • immunoprecipitation; human; fig 2b
In order to characterize the interaction between TRF1 and Plk1, Invitrogen Plk1 antibody (Zymed, 33-1700) was used in immunoprecipitation on human samples (fig 2b). J Biol Chem (2008) ncbi
mouse monoclonal (PL6/PL2)
  • immunoprecipitation; human
  • western blot; human
In order to report PLK1-mediated and phosphor-dependent transcriptional deactivation of TAp73, Invitrogen Plk1 antibody (Zymed Laboratories, 33-1700) was used in immunoprecipitation on human samples and in western blot on human samples . Cell Cycle (2008) ncbi
mouse monoclonal (PL6/PL2)
  • western blot; human; fig 2
In order to assess if histone deacetylase inhibitors affect radiation-induced tumor cell death, Invitrogen Plk1 antibody (Zymed, 33-1700) was used in western blot on human samples (fig 2). Radiat Oncol (2006) ncbi
mouse monoclonal (35-206)
  • immunoprecipitation; human
  • immunocytochemistry; human
  • western blot; human
In order to elucidate how Cep55 regulates cytokinesis, Invitrogen Plk1 antibody (Zymed, 37-7000) was used in immunoprecipitation on human samples , in immunocytochemistry on human samples and in western blot on human samples . Dev Cell (2005) ncbi
mouse monoclonal (PL6/PL2)
  • western blot; human; fig 1B
In order to determine the gene expression profiles of irradiated Reh and U698 cells, Invitrogen Plk1 antibody (Zymed, 33-170) was used in western blot on human samples (fig 1B). Int J Cancer (2005) ncbi
mouse monoclonal (PL6/PL2)
  • immunocytochemistry; human; 5 ug/ml; fig 6
  • western blot; human; fig 2B
In order to report that Plk1 is required for Emi1 destruction during mitosis, Invitrogen Plk1 antibody (Zymed, 33-1700) was used in immunocytochemistry on human samples at 5 ug/ml (fig 6) and in western blot on human samples (fig 2B). Mol Biol Cell (2004) ncbi
mouse monoclonal (PL6/PL2)
  • western blot; human; fig 6
In order to assess global gene expression using p53-deficient human cells to identify genes with G(2)/M-specific and DNA damage-responsive expression, Invitrogen Plk1 antibody (Zymed Laboratories, 33-1700) was used in western blot on human samples (fig 6). J Biol Chem (2001) ncbi
Abcam
mouse monoclonal (35-206)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 6d
Abcam Plk1 antibody (Abcam, ab17056) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 6d). Dis Markers (2021) ncbi
mouse monoclonal (35-206)
  • western blot; human; loading ...; fig 7a, 8a
Abcam Plk1 antibody (Abcam, 17056) was used in western blot on human samples (fig 7a, 8a). Mol Cell Biol (2020) ncbi
domestic rabbit monoclonal (EPNCIR167)
  • immunohistochemistry - paraffin section; human; 1:5000; loading ...; fig s10a
Abcam Plk1 antibody (Abcam, ab155095) was used in immunohistochemistry - paraffin section on human samples at 1:5000 (fig s10a). Nat Commun (2020) ncbi
mouse monoclonal (36-298)
  • western blot; mouse; 1:2000; loading ...; fig 2b
Abcam Plk1 antibody (Abcam, ab178666) was used in western blot on mouse samples at 1:2000 (fig 2b). Mol Cell (2019) ncbi
domestic rabbit monoclonal (EPNCIR167)
  • proximity ligation assay; human; 1:200; loading ...; fig s2c
  • immunocytochemistry; human; 1:2000; loading ...; fig s2f
  • western blot; human; 1:2000; loading ...; fig 2e
Abcam Plk1 antibody (Abcam, ab155095) was used in proximity ligation assay on human samples at 1:200 (fig s2c), in immunocytochemistry on human samples at 1:2000 (fig s2f) and in western blot on human samples at 1:2000 (fig 2e). Mol Cell (2019) ncbi
mouse monoclonal (36-298)
  • immunocytochemistry; human; 1:300; loading ...; fig s7d
Abcam Plk1 antibody (Abcam, ab17057) was used in immunocytochemistry on human samples at 1:300 (fig s7d). J Biol Chem (2018) ncbi
mouse monoclonal (35-206)
  • immunohistochemistry; mouse; loading ...; fig s2h
In order to understand the role of RPL10L in male meiotic division, Abcam Plk1 antibody (Abcam, ab17056) was used in immunohistochemistry on mouse samples (fig s2h). Curr Biol (2017) ncbi
domestic rabbit monoclonal (EPNCIR167)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 3b
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 2b
  • western blot; mouse; 1:30,000; loading ...; fig 1a
In order to assess structural and biochemical phenotypes of neuronal transcriptional repression-induced atypical cell death in patient brains with Huntington's disease, Abcam Plk1 antibody (Abcam, ab155095) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 3b), in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 2b) and in western blot on mouse samples at 1:30,000 (fig 1a). Acta Neuropathol Commun (2017) ncbi
mouse monoclonal (35-206)
  • immunocytochemistry; human; loading ...; fig 8b
In order to demonstrate that INPP5E regulates cell division, Abcam Plk1 antibody (Abcam, ab17056) was used in immunocytochemistry on human samples (fig 8b). Mol Cell Biol (2017) ncbi
mouse monoclonal (36-298)
  • western blot; human; loading ...; fig 1d
In order to report that inhibition of PP2A kills PLK1-overexpressing breast, pancreatic, ovarian, glioblastoma, and prostate cancer cells, Abcam Plk1 antibody (Abcam, ab17057) was used in western blot on human samples (fig 1d). Oncotarget (2016) ncbi
mouse monoclonal (35-206)
  • western blot; mouse; fig 1
Abcam Plk1 antibody (Abcam, ab17056) was used in western blot on mouse samples (fig 1). Cell Rep (2016) ncbi
mouse monoclonal (35-206)
  • western blot; mouse; loading ...; fig 4a
In order to research the role of PCBP1/HNRNP E1 in chromosomal integrity, Abcam Plk1 antibody (Abcam, ab17056) was used in western blot on mouse samples (fig 4a). Mol Cancer Res (2016) ncbi
mouse monoclonal (36-298)
  • immunocytochemistry; human; 1:200; fig 3a
Abcam Plk1 antibody (Abcam, ab17057) was used in immunocytochemistry on human samples at 1:200 (fig 3a). Biol Open (2015) ncbi
mouse monoclonal (2A3)
  • immunocytochemistry; human; 1:300; fig 4a
  • western blot; human; 1:1000; fig 4b
Abcam Plk1 antibody (Abcam, ab39068) was used in immunocytochemistry on human samples at 1:300 (fig 4a) and in western blot on human samples at 1:1000 (fig 4b). Biol Open (2015) ncbi
mouse monoclonal (36-298)
  • western blot; human; 1:500
In order to study the role of the pericentriolar material disassembly in centriole separation during mitotic exit, Abcam Plk1 antibody (Abcam, ab17057) was used in western blot on human samples at 1:500. PLoS ONE (2015) ncbi
mouse monoclonal (36-298)
  • immunocytochemistry; human; 1:500; fig 2
In order to report that RSF1 localizes at mitotic kinetochores and directly binds PLK1, Abcam Plk1 antibody (Abcam, 17057) was used in immunocytochemistry on human samples at 1:500 (fig 2). Nat Commun (2015) ncbi
mouse monoclonal (35-206)
  • immunohistochemistry; mouse; 1:1000; fig s11
Abcam Plk1 antibody (Abcam, Ab17056) was used in immunohistochemistry on mouse samples at 1:1000 (fig s11). Nat Commun (2015) ncbi
mouse monoclonal (36-298)
  • western blot; hamsters
Abcam Plk1 antibody (Abcam, ab17057) was used in western blot on hamsters samples . Int J Biochem Cell Biol (2015) ncbi
mouse monoclonal (35-206)
  • immunocytochemistry; mouse; 1:1000
  • western blot; mouse; 1:1000
In order to search for a conserved mechanism for meiotic kinetochore regulation and identify MEIKIN in mice, Abcam Plk1 antibody (Abcam, ab17056) was used in immunocytochemistry on mouse samples at 1:1000 and in western blot on mouse samples at 1:1000. Nature (2015) ncbi
mouse monoclonal (2A3)
  • western blot; fruit fly ; 1:100
Abcam Plk1 antibody (Abcam, ab39068) was used in western blot on fruit fly samples at 1:100. Open Biol (2014) ncbi
mouse monoclonal (36-298)
  • western blot; human
In order to characterize human NEK7 interactome, Abcam Plk1 antibody (Abcam, ab17057) was used in western blot on human samples . J Proteome Res (2014) ncbi
mouse monoclonal (36-298)
  • immunocytochemistry; human
Abcam Plk1 antibody (Abcam, 17057) was used in immunocytochemistry on human samples . Mol Cancer Ther (2014) ncbi
mouse monoclonal (2A3)
  • western blot; human; 1:1000
Abcam Plk1 antibody (Abcam, ab39068) was used in western blot on human samples at 1:1000. J Biol Chem (2013) ncbi
mouse monoclonal (36-298)
  • immunocytochemistry; human; 1:200
  • western blot; human; 1:1000
Abcam Plk1 antibody (Abcam, ab17057) was used in immunocytochemistry on human samples at 1:200 and in western blot on human samples at 1:1000. J Biol Chem (2013) ncbi
MilliporeSigma
mouse monoclonal (4G11)
  • chromatin immunoprecipitation; human; fig 4e
MilliporeSigma Plk1 antibody (Sigma Aldrich, SAB1404220) was used in chromatin immunoprecipitation on human samples (fig 4e). PLoS Pathog (2021) ncbi
OriGene
mouse monoclonal (OTI8C12)
  • immunohistochemistry; human; 1:50; loading ...; fig 10a
OriGene Plk1 antibody (ORIGENE, TA500393S) was used in immunohistochemistry on human samples at 1:50 (fig 10a). Aging (Albany NY) (2020) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot; mouse; 1:2000; loading ...; fig s6a
Cell Signaling Technology Plk1 antibody (Cell Signaling Technology, 4535) was used in western blot on mouse samples at 1:2000 (fig s6a). Nat Commun (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 1b
In order to use polo-like kinase 1 inhibitors for a rationally designed chemotherapy protocols to treat patients with metastasized retinoblastoma, Cell Signaling Technology Plk1 antibody (Cell Signaling, 4535) was used in western blot on human samples at 1:1000 (fig 1b). Clin Exp Ophthalmol (2017) ncbi
Articles Reviewed
  1. Bian Y, Sui Q, Bi G, Zheng Y, Zhao M, Yao G, et al. Identification and Validation of a Proliferation-Associated Score Model Predicting Survival in Lung Adenocarcinomas. Dis Markers. 2021;2021:3219594 pubmed publisher
  2. Biswas A, Zhou D, Fiches G, Wu Z, Liu X, Ma Q, et al. Inhibition of polo-like kinase 1 (PLK1) facilitates reactivation of gamma-herpesviruses and their elimination. PLoS Pathog. 2021;17:e1009764 pubmed publisher
  3. Kasahara Y, Osuka S, Takasaki N, Bayasula -, Koya Y, Nakanishi N, et al. Primate-specific POTE-actin gene could play a role in human folliculogenesis by controlling the proliferation of granulosa cells. Cell Death Discov. 2021;7:186 pubmed publisher
  4. Liu Z, Zhong J, Cai C, Lu J, Wu W, Zeng G. Immune-related biomarker risk score predicts prognosis in prostate cancer. Aging (Albany NY). 2020;12:22776-22793 pubmed publisher
  5. Douglas P, Ye R, Radhamani S, Cobban A, Jenkins N, Bartlett E, et al. Nocodazole-Induced Expression and Phosphorylation of Anillin and Other Mitotic Proteins Are Decreased in DNA-Dependent Protein Kinase Catalytic Subunit-Deficient Cells and Rescued by Inhibition of the Anaphase-Promoting Complex/Cyclosome with proTAME. Mol Cell Biol. 2020;40: pubmed publisher
  6. Viol L, Hata S, Pastor Peidro A, Neuner A, Murke F, Wuchter P, et al. Nek2 kinase displaces distal appendages from the mother centriole prior to mitosis. J Cell Biol. 2020;219: pubmed publisher
  7. Tanaka H, Homma H, Fujita K, Kondo K, Yamada S, Jin X, et al. YAP-dependent necrosis occurs in early stages of Alzheimer's disease and regulates mouse model pathology. Nat Commun. 2020;11:507 pubmed publisher
  8. Lindel F, Dodt C, Weidner N, Noll M, Bergemann F, Behrendt R, et al. TraFo-CRISPR: Enhanced Genome Engineering by Transient Foamy Virus Vector-Mediated Delivery of CRISPR/Cas9 Components. Mol Ther Nucleic Acids. 2019;18:708-726 pubmed publisher
  9. van de Kooij B, Creixell P, van Vlimmeren A, Joughin B, Miller C, Haider N, et al. Comprehensive substrate specificity profiling of the human Nek kinome reveals unexpected signaling outputs. elife. 2019;8: pubmed publisher
  10. Li W, Wang H, Zhao X, Duan H, Cheng B, Liu Y, et al. A methylation-phosphorylation switch determines Plk1 kinase activity and function in DNA damage repair. Sci Adv. 2019;5:eaau7566 pubmed publisher
  11. Liccardi G, Ramos Garcia L, Tenev T, Annibaldi A, Legrand A, Robertson D, et al. RIPK1 and Caspase-8 Ensure Chromosome Stability Independently of Their Role in Cell Death and Inflammation. Mol Cell. 2019;73:413-428.e7 pubmed publisher
  12. Izumi T, Imai J, Yamamoto J, Kawana Y, Endo A, Sugawara H, et al. Vagus-macrophage-hepatocyte link promotes post-injury liver regeneration and whole-body survival through hepatic FoxM1 activation. Nat Commun. 2018;9:5300 pubmed publisher
  13. Ciossani G, Overlack K, Petrovic A, Huis In t Veld P, Koerner C, Wohlgemuth S, et al. The kinetochore proteins CENP-E and CENP-F directly and specifically interact with distinct BUB mitotic checkpoint Ser/Thr kinases. J Biol Chem. 2018;293:10084-10101 pubmed publisher
  14. Zhang J, Bu X, Wang H, Zhu Y, Geng Y, Nihira N, et al. Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance. Nature. 2018;553:91-95 pubmed publisher
  15. Takaki T, Montagner M, Serres M, Le Berre M, Russell M, Collinson L, et al. Actomyosin drives cancer cell nuclear dysmorphia and threatens genome stability. Nat Commun. 2017;8:16013 pubmed publisher
  16. Tan S, Chadha S, Liu Y, Gabasova E, Perera D, Ahmed K, et al. A Class of Environmental and Endogenous Toxins Induces BRCA2 Haploinsufficiency and Genome Instability. Cell. 2017;169:1105-1118.e15 pubmed publisher
  17. Jiang L, Li T, Zhang X, Zhang B, Yu C, Li Y, et al. RPL10L Is Required for Male Meiotic Division by Compensating for RPL10 during Meiotic Sex Chromosome Inactivation in Mice. Curr Biol. 2017;27:1498-1505.e6 pubmed publisher
  18. Yuan X, Sun X, Shi X, Jiang C, Yu D, Zhang W, et al. USP39 regulates the growth of SMMC-7721 cells via FoxM1. Exp Ther Med. 2017;13:1506-1513 pubmed publisher
  19. Yamanishi E, Hasegawa K, Fujita K, Ichinose S, Yagishita S, Murata M, et al. A novel form of necrosis, TRIAD, occurs in human Huntington's disease. Acta Neuropathol Commun. 2017;5:19 pubmed publisher
  20. Vallejo A, Perurena N, Guruceaga E, Mazur P, Martínez Canarias S, Zandueta C, et al. An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer. Nat Commun. 2017;8:14294 pubmed publisher
  21. Shumilov A, Tsai M, Schlosser Y, Kratz A, Bernhardt K, Fink S, et al. Epstein-Barr virus particles induce centrosome amplification and chromosomal instability. Nat Commun. 2017;8:14257 pubmed publisher
  22. Ruf S, Heberle A, Langelaar Makkinje M, Gelino S, Wilkinson D, Gerbeth C, et al. PLK1 (polo like kinase 1) inhibits MTOR complex 1 and promotes autophagy. Autophagy. 2017;13:486-505 pubmed publisher
  23. Sierra Potchanant E, Cerabona D, Sater Z, He Y, Sun Z, Gehlhausen J, et al. INPP5E Preserves Genomic Stability through Regulation of Mitosis. Mol Cell Biol. 2017;37: pubmed publisher
  24. Cholewa B, Ndiaye M, Huang W, Liu X, Ahmad N. Small molecule inhibition of polo-like kinase 1 by volasertib (BI 6727) causes significant melanoma growth delay and regression in vivo. Cancer Lett. 2017;385:179-187 pubmed publisher
  25. Schwermer M, Dreesmann S, Eggert A, Althoff K, Steenpass L, Schramm A, et al. Pharmaceutically inhibiting polo-like kinase 1 exerts a broad anti-tumour activity in retinoblastoma cell lines. Clin Exp Ophthalmol. 2017;45:288-296 pubmed publisher
  26. Cunningham C, Li S, Vizeacoumar F, Bhanumathy K, Lee J, Parameswaran S, et al. Therapeutic relevance of the protein phosphatase 2A in cancer. Oncotarget. 2016;7:61544-61561 pubmed publisher
  27. Liu J, Wan L, Liu J, Yuan Z, Zhang J, Guo J, et al. Cdh1 inhibits WWP2-mediated ubiquitination of PTEN to suppress tumorigenesis in an APC-independent manner. Cell Discov. 2016;2:15044 pubmed publisher
  28. Chung H, Park J, Lee N, Kim H, Jang C. Phosphorylation of Astrin Regulates Its Kinetochore Function. J Biol Chem. 2016;291:17579-92 pubmed publisher
  29. Engel K, Rudelius M, Slawska J, Jacobs L, Ahangarian Abhari B, Altmann B, et al. USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma. EMBO Mol Med. 2016;8:851-62 pubmed publisher
  30. Jayashree B, Srimany A, Jayaraman S, Bhutra A, Janakiraman N, Chitipothu S, et al. Monitoring of changes in lipid profiles during PLK1 knockdown in cancer cells using DESI MS. Anal Bioanal Chem. 2016;408:5623-32 pubmed publisher
  31. Wang Z, Shen L, Chang C, Zhang X, Chen Z, Li L, et al. Long noncoding RNA lnc-RI is a new regulator of mitosis via targeting miRNA-210-3p to release PLK1 mRNA activity. Sci Rep. 2016;6:25385 pubmed publisher
  32. Ho T, Guilbaud G, Blow J, Sale J, Watson C. The KRAB Zinc Finger Protein Roma/Zfp157 Is a Critical Regulator of Cell-Cycle Progression and Genomic Stability. Cell Rep. 2016;15:724-734 pubmed publisher
  33. Mao Y, Tamura T, Yuki Y, Abe D, Tamada Y, Imoto S, et al. The hnRNP-Htt axis regulates necrotic cell death induced by transcriptional repression through impaired RNA splicing. Cell Death Dis. 2016;7:e2207 pubmed publisher
  34. Link L, Howley B, Hussey G, Howe P. PCBP1/HNRNP E1 Protects Chromosomal Integrity by Translational Regulation of CDC27. Mol Cancer Res. 2016;14:634-46 pubmed publisher
  35. Wu J, Ivanov A, Fisher P, Fu Z. Polo-like kinase 1 induces epithelial-to-mesenchymal transition and promotes epithelial cell motility by activating CRAF/ERK signaling. elife. 2016;5: pubmed publisher
  36. Zhao W, Liu J, Zhang X, Deng L. MLL5 maintains spindle bipolarity by preventing aberrant cytosolic aggregation of PLK1. J Cell Biol. 2016;212:829-43 pubmed publisher
  37. Ercilla A, Llopis A, Feu S, Aranda S, Ernfors P, Freire R, et al. New origin firing is inhibited by APC/CCdh1 activation in S-phase after severe replication stress. Nucleic Acids Res. 2016;44:4745-62 pubmed publisher
  38. Lasek A, McPherson B, Trueman N, Burkard M. The Functional Significance of Posttranslational Modifications on Polo-Like Kinase 1 Revealed by Chemical Genetic Complementation. PLoS ONE. 2016;11:e0150225 pubmed publisher
  39. Chen N, Chyau C, Lee Y, Tseng H, Chou F. Promotion of mitotic catastrophe via activation of PTEN by paclitaxel with supplement of mulberry water extract in bladder cancer cells. Sci Rep. 2016;6:20417 pubmed publisher
  40. Moudry P, Watanabe K, Wolanin K, Bartkova J, Wassing I, Watanabe S, et al. TOPBP1 regulates RAD51 phosphorylation and chromatin loading and determines PARP inhibitor sensitivity. J Cell Biol. 2016;212:281-8 pubmed publisher
  41. Hasvold G, Lund Andersen C, Lando M, Patzke S, Hauge S, Suo Z, et al. Hypoxia-induced alterations of G2 checkpoint regulators. Mol Oncol. 2016;10:764-73 pubmed publisher
  42. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  43. Naylor R, Jeganathan K, Cao X, van Deursen J. Nuclear pore protein NUP88 activates anaphase-promoting complex to promote aneuploidy. J Clin Invest. 2016;126:543-59 pubmed publisher
  44. O Connor A, Maffini S, Rainey M, Kaczmarczyk A, Gaboriau D, Musacchio A, et al. Requirement for PLK1 kinase activity in the maintenance of a robust spindle assembly checkpoint. Biol Open. 2015;5:11-9 pubmed publisher
  45. Kim J, Lee K, Rhee K. PLK1 regulation of PCNT cleavage ensures fidelity of centriole separation during mitotic exit. Nat Commun. 2015;6:10076 pubmed publisher
  46. Dibb M, Han N, Choudhury J, Hayes S, Valentine H, West C, et al. FOXM1 and polo-like kinase 1 are co-ordinately overexpressed in patients with gastric adenocarcinomas. BMC Res Notes. 2015;8:676 pubmed publisher
  47. Marangos P, Stevense M, Niaka K, Lagoudaki M, Nabti I, Jessberger R, et al. DNA damage-induced metaphase I arrest is mediated by the spindle assembly checkpoint and maternal age. Nat Commun. 2015;6:8706 pubmed publisher
  48. Seo M, Jang W, Rhee K. Integrity of the Pericentriolar Material Is Essential for Maintaining Centriole Association during M Phase. PLoS ONE. 2015;10:e0138905 pubmed publisher
  49. Nestal de Moraes G, Khongkow P, Gong C, Yao S, Gomes A, Ji Z, et al. Forkhead box K2 modulates epirubicin and paclitaxel sensitivity through FOXO3a in breast cancer. Oncogenesis. 2015;4:e167 pubmed publisher
  50. Shukla A, Kong D, Sharma M, Magidson V, Loncarek J. Plk1 relieves centriole block to reduplication by promoting daughter centriole maturation. Nat Commun. 2015;6:8077 pubmed publisher
  51. Lee H, Park Y, Cho M, Chae S, Yoo Y, Kwon M, et al. The chromatin remodeller RSF1 is essential for PLK1 deposition and function at mitotic kinetochores. Nat Commun. 2015;6:7904 pubmed publisher
  52. Clift D, Schuh M. A three-step MTOC fragmentation mechanism facilitates bipolar spindle assembly in mouse oocytes. Nat Commun. 2015;6:7217 pubmed publisher
  53. Tut T, Lim S, Dissanayake I, Descallar J, Chua W, Ng W, et al. Upregulated Polo-Like Kinase 1 Expression Correlates with Inferior Survival Outcomes in Rectal Cancer. PLoS ONE. 2015;10:e0129313 pubmed publisher
  54. Saini P, Li Y, Dobbelstein M. Wee1 is required to sustain ATR/Chk1 signaling upon replicative stress. Oncotarget. 2015;6:13072-87 pubmed
  55. Zhang Z, Chen L, Wang H, Ahmad N, Liu X. Inhibition of Plk1 represses androgen signaling pathway in castration-resistant prostate cancer. Cell Cycle. 2015;14:2142-8 pubmed publisher
  56. Kobayashi A, Hashizume C, Dowaki T, Wong R. Therapeutic potential of mitotic interaction between the nucleoporin Tpr and aurora kinase A. Cell Cycle. 2015;14:1447-58 pubmed publisher
  57. Voets E, Wolthuis R. MASTL promotes cyclin B1 destruction by enforcing Cdc20-independent binding of cyclin B1 to the APC/C. Biol Open. 2015;4:484-95 pubmed publisher
  58. Wang H, Tian C, Fan X, Chen L, Lv Y, Sun J, et al. Polo-like kinase 3 (PLK3) mediates the clearance of the accumulated PrP mutants transiently expressed in cultured cells and pathogenic PrP(Sc) in prion infected cell line via protein interaction. Int J Biochem Cell Biol. 2015;62:24-35 pubmed publisher
  59. Kratz A, Bärenz F, Richter K, Hoffmann I. Plk4-dependent phosphorylation of STIL is required for centriole duplication. Biol Open. 2015;4:370-7 pubmed publisher
  60. Fan Y, Zhao H, Liu J, Tan T, Ding T, Li R, et al. Aberrant expression of maternal Plk1 and Dctn3 results in the developmental failure of human in-vivo- and in-vitro-matured oocytes. Sci Rep. 2015;5:8192 pubmed publisher
  61. Valianou M, Cox A, Pichette B, Hartley S, Paladhi U, Astrinidis A. Pharmacological inhibition of Polo-like kinase 1 (PLK1) by BI-2536 decreases the viability and survival of hamartin and tuberin deficient cells via induction of apoptosis and attenuation of autophagy. Cell Cycle. 2015;14:399-407 pubmed publisher
  62. Thomas Y, Peter M, Mechali F, Blanchard J, Coux O, Baldin V. Kizuna is a novel mitotic substrate for CDC25B phosphatase. Cell Cycle. 2014;13:3867-77 pubmed publisher
  63. Kim J, Ishiguro K, Nambu A, Akiyoshi B, Yokobayashi S, Kagami A, et al. Meikin is a conserved regulator of meiosis-I-specific kinetochore function. Nature. 2015;517:466-71 pubmed publisher
  64. Choi M, Kim W, Cheon M, Lee C, Kim J. Polo-like kinase 1 inhibitor BI2536 causes mitotic catastrophe following activation of the spindle assembly checkpoint in non-small cell lung cancer cells. Cancer Lett. 2015;357:591-601 pubmed publisher
  65. Bastos R, Cundell M, Barr F. KIF4A and PP2A-B56 form a spatially restricted feedback loop opposing Aurora B at the anaphase central spindle. J Cell Biol. 2014;207:683-93 pubmed publisher
  66. Shao C, Ahmad N, Hodges K, Kuang S, Ratliff T, Liu X. Inhibition of polo-like kinase 1 (Plk1) enhances the antineoplastic activity of metformin in prostate cancer. J Biol Chem. 2015;290:2024-33 pubmed publisher
  67. Carmena M, Lombardía M, Ogawa H, Earnshaw W. Polo kinase regulates the localization and activity of the chromosomal passenger complex in meiosis and mitosis in Drosophila melanogaster. Open Biol. 2014;4:140162 pubmed publisher
  68. Wang D, Zhang P, Gao K, Tang Y, Jin X, Zhang Y, et al. PLK1 and β-TrCP-dependent ubiquitination and degradation of Rap1GAP controls cell proliferation. PLoS ONE. 2014;9:e110296 pubmed publisher
  69. van der Lelij P, Stocsits R, Ladurner R, Petzold G, Kreidl E, Koch B, et al. SNW1 enables sister chromatid cohesion by mediating the splicing of sororin and APC2 pre-mRNAs. EMBO J. 2014;33:2643-58 pubmed publisher
  70. Chan Y, West S. Spatial control of the GEN1 Holliday junction resolvase ensures genome stability. Nat Commun. 2014;5:4844 pubmed publisher
  71. de Souza E, Meirelles G, Godoy B, Perez A, Smetana J, Doxsey S, et al. Characterization of the human NEK7 interactome suggests catalytic and regulatory properties distinct from those of NEK6. J Proteome Res. 2014;13:4074-90 pubmed publisher
  72. Vassilopoulos A, Tominaga Y, Kim H, Lahusen T, Li B, Yu H, et al. WEE1 murine deficiency induces hyper-activation of APC/C and results in genomic instability and carcinogenesis. Oncogene. 2015;34:3023-35 pubmed publisher
  73. Van Der Meer R, Song H, Park S, Abdulkadir S, Roh M. RNAi screen identifies a synthetic lethal interaction between PIM1 overexpression and PLK1 inhibition. Clin Cancer Res. 2014;20:3211-21 pubmed publisher
  74. Mäki Jouppila J, Laine L, Rehnberg J, Narvi E, Tiikkainen P, Hukasova E, et al. Centmitor-1, a novel acridinyl-acetohydrazide, possesses similar molecular interaction field and antimitotic cellular phenotype as rigosertib, on 01910.Na. Mol Cancer Ther. 2014;13:1054-66 pubmed publisher
  75. Akiyama M, Izumi H, Wang K, Yamaguchi T, Kuma A, Kitamura N, et al. Hypersensitivity to aurora kinase inhibitors in cells resistant against platinum- containing anticancer agents. Anticancer Agents Med Chem. 2014;14:1042-50 pubmed
  76. Matthess Y, Raab M, Knecht R, Becker S, Strebhardt K. Sequential Cdk1 and Plk1 phosphorylation of caspase-8 triggers apoptotic cell death during mitosis. Mol Oncol. 2014;8:596-608 pubmed publisher
  77. Wu D, Asiedu M, Matsumura F, Wei Q. Phosphorylation of myosin II-interacting guanine nucleotide exchange factor (MyoGEF) at threonine 544 by aurora B kinase promotes the binding of polo-like kinase 1 to MyoGEF. J Biol Chem. 2014;289:7142-50 pubmed publisher
  78. Laguette N, Brégnard C, Hue P, Basbous J, Yatim A, Larroque M, et al. Premature activation of the SLX4 complex by Vpr promotes G2/M arrest and escape from innate immune sensing. Cell. 2014;156:134-45 pubmed publisher
  79. Ando K, Ozaki T, Hirota T, Nakagawara A. NFBD1/MDC1 is phosphorylated by PLK1 and controls G2/M transition through the regulation of a TOPOII?-mediated decatenation checkpoint. PLoS ONE. 2013;8:e82744 pubmed publisher
  80. Yu Y, Munger K. Human papillomavirus type 16 E7 oncoprotein inhibits the anaphase promoting complex/cyclosome activity by dysregulating EMI1 expression in mitosis. Virology. 2013;446:251-9 pubmed publisher
  81. Tan E, Caro S, Potnis A, Lanza C, Slawson C. O-linked N-acetylglucosamine cycling regulates mitotic spindle organization. J Biol Chem. 2013;288:27085-99 pubmed publisher
  82. Nakamura T, Saito H, Takekawa M. SAPK pathways and p53 cooperatively regulate PLK4 activity and centrosome integrity under stress. Nat Commun. 2013;4:1775 pubmed publisher
  83. Gao M, Rendtlew Danielsen J, Wei L, Zhou D, Xu Q, Li M, et al. A novel role of human holliday junction resolvase GEN1 in the maintenance of centrosome integrity. PLoS ONE. 2012;7:e49687 pubmed publisher
  84. Ovejero S, Ayala P, Bueno A, Sacristán M. Human Cdc14A regulates Wee1 stability by counteracting CDK-mediated phosphorylation. Mol Biol Cell. 2012;23:4515-25 pubmed publisher
  85. Kubara P, Kernéis Golsteyn S, Studény A, Lanser B, Meijer L, Golsteyn R. Human cells enter mitosis with damaged DNA after treatment with pharmacological concentrations of genotoxic agents. Biochem J. 2012;446:373-81 pubmed publisher
  86. Hwang H, Ji J, Jang Y. Phosphorylation of Ran-binding protein-1 by Polo-like kinase-1 is required for interaction with Ran and early mitotic progression. J Biol Chem. 2011;286:33012-20 pubmed publisher
  87. Landsverk K, Patzke S, Rein I, Stokke C, Lyng H, De Angelis P, et al. Three independent mechanisms for arrest in G2 after ionizing radiation. Cell Cycle. 2011;10:819-29 pubmed
  88. Ito T, Sato F, Kan T, Cheng Y, David S, Agarwal R, et al. Polo-like kinase 1 regulates cell proliferation and is targeted by miR-593* in esophageal cancer. Int J Cancer. 2011;129:2134-46 pubmed publisher
  89. Lee J, Kim J, Margolis R, Fotedar R. Substrate degradation by the anaphase promoting complex occurs during mitotic slippage. Cell Cycle. 2010;9:1792-801 pubmed
  90. Lee J, Kim J, Barbier V, Fotedar A, Fotedar R. DNA damage triggers p21WAF1-dependent Emi1 down-regulation that maintains G2 arrest. Mol Biol Cell. 2009;20:1891-902 pubmed publisher
  91. Wu Z, Yang X, Weber G, Liu X. Plk1 phosphorylation of TRF1 is essential for its binding to telomeres. J Biol Chem. 2008;283:25503-13 pubmed publisher
  92. Soond S, Barry S, Melino G, Knight R, Latchman D, Stephanou A. p73-mediated transcriptional activity is negatively regulated by polo-like kinase 1. Cell Cycle. 2008;7:1214-23 pubmed
  93. Flatmark K, Nome R, Folkvord S, Bratland A, Rasmussen H, Ellefsen M, et al. Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibition. Radiat Oncol. 2006;1:25 pubmed
  94. Fabbro M, Zhou B, Takahashi M, Sarcevic B, Lal P, Graham M, et al. Cdk1/Erk2- and Plk1-dependent phosphorylation of a centrosome protein, Cep55, is required for its recruitment to midbody and cytokinesis. Dev Cell. 2005;9:477-88 pubmed
  95. Lyng H, Landsverk K, Kristiansen E, DeAngelis P, Ree A, Myklebost O, et al. Response of malignant B lymphocytes to ionizing radiation: gene expression and genotype. Int J Cancer. 2005;115:935-42 pubmed
  96. Hansen D, Loktev A, Ban K, Jackson P. Plk1 regulates activation of the anaphase promoting complex by phosphorylating and triggering SCFbetaTrCP-dependent destruction of the APC Inhibitor Emi1. Mol Biol Cell. 2004;15:5623-34 pubmed
  97. Crawford D, Piwnica Worms H. The G(2) DNA damage checkpoint delays expression of genes encoding mitotic regulators. J Biol Chem. 2001;276:37166-77 pubmed